Anti-Human Enolase 1/ENO1 Reference Antibody (HuL001, RUO)

Catalog No.	HY081016
Brand	abinScience
Host species	Human
Species reactivity	Human
Form	Liquid
Storage buffer	0.01M PBS pH 7.4
Purity	>95% purity as determined by SDS-PAGE.
Clonality	Monoclonal
Isotype	IgG
Applications	ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Target	Non-neural enolase, 2-phospho-D-glycerate hydro-lyase, MPB-1, ENO1, Plasminogen-binding protein, Enolase 1, C-myc promoter-binding protein, Alpha-enolase, MBP-1, MBPB1, MPB1, ENO1L1, NNE, Phosphopyruvate hydratase
References	1. Chao, K.S.C. et al. Tilting Immunometabolic Balance of Tumor Microenvironment by Targeting ENO1 in KRAS-Mutated Colorectal and Pancreatic Cancers. International Journal of Radiation Oncology, Biology, Physics, Volume 120, Issue 2, S97 [HY081016] 2. Maisie Huang, et al. Abstract LB067: Extracellular enolase-1 drives cancer-associated fibroblast differentiation in the tumor microenvironment to enhance tumor growth of multiple myeloma: Development of the therapeutic antibody, HuL001. Cancer Res 15 April 2025; 85 (8_Supplement_2): LB067. [HY081016]
Purification	Protein A/G purified from cell culture supernatant.
Biological activity	HuL001 inhibits cancer-associated fibroblast-mediated tumor progression in a bortezomib ()-resistant multiple myeloma xenograft model [2].
Endotoxin level	< 10 EU/mg
Expression system	Mammalian cells
Accession	P06733
Stability and Storage	Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative name	HuL001
Clone ID	HuL001
Note	For research use only. Not suitable for clinical or therapeutic use.